Big Pharma Earnings Watch: Johnson & Johnson

Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019 It’s that time again. Pharmaceutical companies are starting to report their earnings for Q2. Big Pharma giant Johnson

07-17-2019 Read More

CSRxP Encourages House E&C Lawmakers to Advance FAIR Drug Pricing Act

Greater List Price Transparency Will Help Hold Big Pharma Accountable, Deter Price-Gouging For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The

07-16-2019 Read More

Big Pharma Watch: Manufacturers Thumb Nose at Drug Price Crisis

Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability The summer is heating up and so too is Big Pharma’s zeal for putting profits over people. Brand name drug makers

07-12-2019 Read More

Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule

America’s seniors and taxpayers received a huge win today when the administration made the right call to withdraw a proposal, known as the Rebate Rule, from the Department of Health and Human

07-12-2019 Read More

CSRxP Applauds Administration for Withdrawal of Controversial Rebate Rule

Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors & Taxpayers, Loss for Big Pharma For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington

07-11-2019 Read More

CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse

Proposed Bill Would Undermine Fair and Efficient Review Process For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx

07-10-2019 Read More

In Case You Missed It: Congress must capitalize on momentum to hold Big Pharma accountable

Lauren Aronson The Hill July 9, 2019 The American people are demanding that Congress hold Big Pharma accountable and the momentum to lower prescription drug prices has never been greater. For years

07-9-2019 Read More

CSRxP: Judiciary Committee Cracks Down on Big Pharma’s Anti-Competitive Tactics

Senators Advance Three Measures to Help Lower Drug Prices as Momentum to Hold Drug Makers Accountable Builds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.

06-27-2019 Read More

CSRxP Applauds Senate HELP Committee For Advancing Bipartisan Measures to Hold Big Pharma Accountable and Lower Drug Prices

Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting Competition and Transparency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C.

06-26-2019 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.